| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0.003 | 0.995 | Antiinflammatory | 0.995 0.003 DBMET02758 | ||
| 0.988 | 0.001 | 0.988 | Hypoxia-inducible factor 1 alpha inhibitor | 0.923 0.002 DBMET02758 | ||
| 0.964 | 0.004 | 0.964 | Toll-Like receptor agonist | 0.964 0.004 DBMET02758 | ||
| 0.963 | 0.004 | 0.963 | Toll-Like receptor 7 agonist | 0.963 0.004 DBMET02758 | ||
| 0.956 | 0.001 | 0.956 | Antipruritic | 0.884 0.002 DBMET02758 | ||
| 0.935 | 0.004 | 0.935 | Transcription factor NF kappa B inhibitor | 0.918 0.005 DBMET02758 | ||
| 0.901 | 0 | 0.901 | Transcortin receptor antagonist | 0.751 0 DBMET02758 | ||
| 0.888 | 0 | 0.888 | Glucocorticoid agonist | 0.875 0 DBMET02758 | ||
| 0.878 | 0.001 | 0.878 | Glucocorticoid antagonist | 0.827 0.001 DBMET02758 | ||
| 0.874 | 0.001 | 0.874 | Androgen agonist | 0.555 0.002 DBMET02758 | ||
| 0.861 | 0.002 | 0.861 | Androgen antagonist | 0.581 0.003 DBMET02758 | ||
| 0.797 | 0.004 | 0.797 | Immunosuppressant | 0.796 0.004 DBMET02758 | ||
| 0.771 | 0.003 | 0.771 | Interleukin 4 antagonist | 0.738 0.003 DBMET02758 | ||
| 0.726 | 0.003 | 0.726 | NOS3 expression enhancer | 0.701 0.003 DBMET02758 | ||
| 0.692 | 0.002 | 0.692 | Progesterone antagonist | 0.548 0.002 DBMET02758 | ||
| 0.674 | 0 | 0.674 | Corticosteroid-like | 0.619 0 DBMET02758 | ||
| 0.643 | 0.002 | 0.643 | Interferon gamma antagonist | 0.598 0.002 DBMET02758 | ||
| 0.619 | 0 | 0.619 | Arachidonic acid antagonist | 0.467 0 DBMET02758 | ||
| 0.558 | 0 | 0.558 | Lipocortins synthesis agonist | 0.52 0 DBMET02758 | ||
| 0.556 | 0.003 | 0.556 | Interleukin 5 antagonist | 0.525 0.003 DBMET02758 | ||
| 0.596 | 0.05 | 0.596 | Apoptosis agonist | 0.532 0.065 DBMET02758 | ||
| 0.535 | 0.003 | 0.535 | Lipocortins synthesis antagonist | 0.491 0.004 DBMET02758 | ||
| 0.516 | 0.015 | 0.542 | Nitric oxide antagonist | 0.542 0.013 DBMET02758 | DBMET02758 | |
| 0.49 | 0.009 | 0.527 | P-glycoprotein inhibitor | 0.527 0.007 DBMET02758 | DBMET02758 | |
| 0.424 | 0.011 | 0.424 | Sodium/bile acid cotransporter inhibitor | 0.414 0.013 DBMET02758 | ||
| 0.403 | 0.004 | 0.403 | Aromatase inhibitor | 0.367 0.004 DBMET02758 | ||
| 0.392 | 0.002 | 0.392 | Aldosterone antagonist | 0.209 0.004 DBMET02758 | ||
| 0.383 | 0.038 | 0.383 | Antioxidant | 0.369 0.041 DBMET02758 | ||
| 0.395 | 0.051 | 0.395 | Immunostimulant | 0.321 0.073 DBMET02758 | ||
| 0.356 | 0.029 | 0.356 | DNA synthesis inhibitor | 0.307 0.041 DBMET02758 | ||
| 0.328 | 0.001 | 0.328 | Anabolic | 0.24 0.002 DBMET02758 | ||
| 0.26 | 0.004 | 0.26 | Mineralocorticoid receptor antagonist | 0.188 0.004 DBMET02758 | ||
| 0.257 | 0.005 | 0.257 | T cell inhibitor | 0.221 0.007 DBMET02758 | ||
| 0.327 | 0.075 | 0.327 | Cholesterol antagonist | 0.197 0.167 DBMET02758 | ||
| 0.286 | 0.037 | 0.286 | Anesthetic general | 0.16 0.104 DBMET02758 | ||
| 0.273 | 0.027 | 0.273 | Diuretic | 0.153 0.075 DBMET02758 | ||
| 0.247 | 0.025 | 0.247 | Topoisomerase II inhibitor | 0.233 0.027 DBMET02758 | ||
| 0.275 | 0.054 | 0.275 | Interleukin antagonist | 0.236 0.067 DBMET02758 | ||
| 0.243 | 0.024 | 0.243 | Interleukin 6 antagonist | 0.237 0.026 DBMET02758 | ||
| 0.252 | 0.043 | 0.252 | Hepatoprotectant | 0.25 0.043 DBMET02758 | ||
| 0.279 | 0.072 | 0.279 | Aldehyde oxidase inhibitor | 0.199 0.105 DBMET02758 | ||
| 0.215 | 0.011 | 0.215 | Estrogen antagonist | 0.176 0.016 DBMET02758 | ||
| 0.224 | 0.029 | 0.224 | Cytokine production inhibitor | 0.147 0.064 DBMET02758 | ||
| 0.206 | 0.014 | 0.206 | Topoisomerase II alpha inhibitor | 0.197 0.015 DBMET02758 | ||
| 0.198 | 0.021 | 0.224 | Antineoplastic antibiotic | 0.224 0.017 DBMET02758 | DBMET02758 | |
| 0.21 | 0.038 | 0.21 | Lipid peroxidase inhibitor | 0.166 0.058 DBMET02758 | ||
| 0.267 | 0.1 | 0.267 | Interleukin 2 agonist | |||
| 0.206 | 0.049 | 0.206 | Thrombolytic | 0.177 0.064 DBMET02758 | ||
| 0.262 | 0.106 | 0.275 | Immunomodulator | 0.275 0.096 DBMET02758 | DBMET02758 | |
| 0.176 | 0.02 | 0.176 | Antineoplastic alkaloid | 0.166 0.023 DBMET02758 | ||
| 0.178 | 0.03 | 0.178 | Farnesoid X receptor antagonist | 0.143 0.06 DBMET02758 | ||
| 0.177 | 0.033 | 0.177 | Cholesterol synthesis inhibitor | 0.112 0.073 DBMET02758 | ||
| 0.152 | 0.011 | 0.152 | Estrogen agonist | 0.102 0.017 DBMET02758 | ||
| 0.143 | 0.003 | 0.143 | Nitric oxide donor | 0.14 0.003 DBMET02758 | ||
| 0.149 | 0.016 | 0.149 | Inducible nitric-oxide synthase inhibitor | 0.124 0.023 DBMET02758 | ||
| 0.114 | 0.003 | 0.114 | Progesterone agonist | 0.091 0.004 DBMET02758 | ||
| 0.193 | 0.084 | 0.193 | Neurotrophic factor enhancer | 0.169 0.111 DBMET02758 | ||
| 0.114 | 0.005 | 0.114 | RNA-directed RNA polymerase stimulant | 0.071 0.009 DBMET02758 | ||
| 0.151 | 0.042 | 0.151 | DNA intercalator | 0.131 0.052 DBMET02758 | ||
| 0.284 | 0.178 | 0.284 | Cyclophilin D inhibitor | |||
| 0.12 | 0.017 | 0.12 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 DBMET02758 | ||
| 0.297 | 0.197 | 0.297 | Caspase 9 stimulant | 0.268 0.232 DBMET02758 | ||
| 0.148 | 0.049 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 DBMET02758 | DBMET02758 | |
| 0.091 | 0.003 | 0.091 | Glucose-6-phosphate dehydrogenase inhibitor | 0.083 0.004 DBMET02758 | ||
| 0.165 | 0.083 | 0.165 | Tumour necrosis factor antagonist | |||
| 0.09 | 0.011 | 0.09 | 5-Alpha-reductase inhibitor | |||
| 0.224 | 0.152 | 0.274 | Apoptosis antagonist | 0.274 0.105 DBMET02758 | DBMET02758 | |
| 0.112 | 0.042 | 0.112 | Estrogen receptor beta antagonist | 0.1 0.064 DBMET02758 | ||
| 0.078 | 0.012 | 0.078 | Estrogen receptor alpha agonist | 0.037 0.022 DBMET02758 | ||
| 0.147 | 0.086 | 0.147 | Melanin inhibitor | |||
| 0.17 | 0.11 | 0.17 | Angiogenesis stimulant | |||
| 0.089 | 0.037 | 0.089 | Estrogen receptor alpha antagonist | 0.071 0.065 DBMET02758 | ||
| 0.118 | 0.07 | 0.118 | DNA polymerase I inhibitor | |||
| 0.069 | 0.027 | 0.069 | Heme oxygenase stimulant | 0.063 0.039 DBMET02758 | ||
| 0.234 | 0.192 | 0.274 | Antibacterial | 0.274 0.156 DBMET02758 | DBMET02758 | |
| 0.058 | 0.018 | 0.058 | Estrogen receptor beta agonist | |||
| 0.201 | 0.167 | 0.24 | Caspase 3 stimulant | 0.24 0.121 DBMET02758 | DBMET02758 | |
| 0.109 | 0.076 | 0.109 | Microtubule formation inhibitor | 0.103 0.086 DBMET02758 | ||
| 0.167 | 0.137 | 0.167 | Tumour necrosis factor alpha release inhibitor | |||
| 0.052 | 0.026 | 0.052 | Microtubule stabilization | 0.05 0.028 DBMET02758 | ||
| 0.097 | 0.074 | 0.097 | Toll-Like receptor 4 antagonist | |||
| 0.083 | 0.063 | 0.083 | Transcription factor NF kappa B stimulant | 0.081 0.068 DBMET02758 | ||
| 0.03 | 0.01 | 0.03 | Estrone sulfatase inhibitor | 0.021 0.016 DBMET02758 | ||
| 0.054 | 0.036 | 0.054 | Matrix metalloproteinase 1 inhibitor | |||
| 0.126 | 0.111 | 0.126 | Pregnane X receptor agonist | |||
| 0.021 | 0.012 | 0.021 | 5-Alpha-reductase 2 inhibitor | |||
| 0.012 | 0.009 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.011 0.01 DBMET02758 | ||
| 0.033 | 0.086 | 0.099 | HIV-1 integrase (Strand Transfer) inhibitor | 0.099 0.023 DBMET02758 | DBMET02758 | |
| 0.03 | 0.139 | 0.082 | HIV-1 integrase (3'-Processing) inhibitor | 0.082 0.033 DBMET02758 | DBMET02758 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |